This episode currently has no reviews.
Submit ReviewThe great and brilliant Dr. Kristof Szalay returns to the podcast. Dr. Szalay is CTO and Founder of Turbine.ai, a simulation-driven drug discovery company, delivering targeted cancer therapies to targeted patient populations. Today's episode topics include: how AI integrates with the phases of drug discovery, development, and generally applicable enterprise deployment challenges. Want to discover opportunities to integrate AI in your organization? Try Emerj Plus: emerj.com/p1
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review